Jeito Capital II's €1B European Biopharma Fund: LPs Back EU Healthcare at Scale
Jeito Capital's €1B Fund II cements the case that Europe can fund late-stage biopharma domestically, without exporting all growth-stage capital to the U.S.
paris - VC Tracker Resources
Discover comprehensive resources and guides related to paris. Our comprehensive guides cover VC analysis preparation, investment resources, and practical advice for investors and analysts.
Whether you're an investor preparing for market analysis, a portfolio manager helping with investment tracking, or an analyst looking for resources, you'll find valuable insights in the articles below.
Related Articles (6 articles)
VivaTech 2026 Preview: Paris's June Event Is the Largest EU Startup-Meets-VC Stage
VivaTech 2026 returns June 17–20 with 180,000+ attendees and 3,600+ investors — here's how founders and VCs should play it.
Mistral's $3.1B Stack and Paris Datacenter: Europe's Sovereign AI Bet Gets Real
With €1.7B equity, $830M in debt, and a Paris datacenter plan, Mistral is turning 'European AI sovereignty' into a funded industrial strategy.
Parallel's €17M Series A: Paris Healthtech Doubles Down on Coding Agents
Parallel's Paris round highlights Europe's growing confidence in vertical AI agents for regulated industries like healthcare.
EGIDE's €8M Seed: France Doubles Down on Counter-Drone Capability
EGIDE's Paris seed round is a microcosm of France's push for sovereign counter-UAV systems and dual-use defense tech.
Escape's €15M Series A: Paris Pushes Into AI-Driven API Security
Escape's Series A highlights France's growing presence in AI security tooling — and the need for continuous API attack-surface monitoring.